Decreasing cariogenic bacteria with a natural, alternative prevention therapy utilizing phytochemistry (plant extracts)

Journal of Clinical Pediatric Dentistry

Volumn 36, Issue 1, 2011, Pages 55-64

  Ramakrishna, Y ^a   Goda, H ^a   Baliga, M S ^b   Munshi, A K ^a  

^a KD Dental College and Hospital Mathura   (India)

^b DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimicrobial efficacy; Cariogenic bacteria; Oral microflora; Phytochemicals; Phytosomes; Plant extracts

Indexed keywords

EID: 84855336800     PISSN: 10534628     EISSN: None     Source Type: Journal    
DOI: 10.17796/jcpd.36.1.f485870h90174311     Document Type: Review

References (149)

1. Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century - The approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol, 31(Suppl. 1): 3-24, 2003. (Pubitemid 41719792)
2. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ, 83(9): 661-9, 2005. (Pubitemid 41297069)
3. Rautemaa R, Lauhio A, Cullinan MP, Seymour GJ. Oral infections and systemic disease- an emerging problem in medicine. Clin Microbiol Infect, 13(11): 1041-7, 2007. (Pubitemid 47543104)
4. Peterson PE. The burden of oral disease: challenges to improving oral health in the 21st century. Bull World Health Organ, 83(1): 3, 2005.
5. Jamieson LM, Parker EJ, Armfield JM. Indigenous child oral health at a regional and state level. J Paediatr Child Health, 43(3): 117-21, 2007. (Pubitemid 46213673)
6. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in health. Trends Microbiol, 13(12): 589-95, 2005. (Pubitemid 41661340)
7. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res, 8(2): 263-271, 1994.
8. Kroes I, Leep PW, Relman DA. Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci USA, 96(25): 14547-14552, 1999. (Pubitemid 30000687)
9. Aas JA, Paster BJ, Stokes LN, Oslen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol, 43(11): 5721-5732, 2005. (Pubitemid 41612354)
10. Tencate JM. Biofilms, a new approach to the microbiology of dental plaque. Odontol, 94(1): 1-9, 2006.
11. Kerr WJS, Geddes DAM. The areas of various surfaces in the human mouth from nine years to adulthood. J Dent Res, 70(12): 1528-30, 1991.
12. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol, 25(2): 134-44, 1998. (Pubitemid 128705944)
13. Haffajee AD, Socransky SS, Patel MR, Song X. Microbial complexes in supragingival plaque. Oral Microbiol Immunol, 23(3): 196-205, 2008. (Pubitemid 351519449)
14. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000, 28: 12-55, 2002.
15. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 15(2): 167-93, 2002. (Pubitemid 34303762)
16. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science, 311 (5764): 1113-6, 2006.
17. Kolenbrander PE, London J. Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol, 175(11): 3247-52, 1993. (Pubitemid 23163365)
18. Kreth J, Merritt J, Shi W, Qi F. Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol, 187(21): 7193-203, 2005. (Pubitemid 41507777)
19. Tsuda H, Yamashita Y, Shibata Y, Nakano Y, Koga T. Genes involved in Bacitracin resistance in Streptococcus mutans. Antimicrob Agents Chemother, 46(12): 3756-64, 2002. (Pubitemid 35403248)
20. Tada A, Senpuku H, Motozawa Y, Yoshihara A, Hanada N, Tanzawa H. Association between commensal bacteria and opportunistic pathogens in the dental plaque of elderly individuals. Clin Microbiol Infect, 12: 776-81, 2006. (Pubitemid 43983803)
21. Bowden GHW, Ellwood DC, Hamilton IR. Microbial ecology of the oral cavity. In: Advances in microbial ecology, Alexander M, Ed., New York: Plenum. Press, 3: 135-217, 1979.
22. Chen YY, Clancy KA, Burne RA. Streptococcus salivarius urease: genetic and biochemical characterization and expression in a dental plaque Streptococcus. Infect Immun, 64(2): 585-92, 1996. (Pubitemid 26032833)
23. Sissons CH, Yakub S. Supression of urease levels in Streptococcus salivarius by cysteine, related compounds and by sulfide. Oral Microbiol Immunol, 15: 317-24, 2000.
24. Kopstein J, Wrong OM. The origin and fate of salivary urea and ammonia in man. Clin Sci Mol Med, 52(1): 9-17, 1977. (Pubitemid 8071178)
25. Golub LM, Borden SM, Kleinberg I. Urea content of gingival crevicular fluid and its relation to periodontal disease in humans. J Periodontal Res, 6: 243-51, 1971.
26. Kleinberg I. Effect of urea concentration on human plaque pH levels in situ. Arch Oral Biol, 12: 1475-84, 1967.
27. Sissons CH, Cutress TW, Pearce EIF. Kinetics and product stoichiometry of ureolysis by human salivary bacteria and artificial mouth plaques. Arch Oral Biol, 30: 781-90, 1985.
28. Sissons CH, Cutress TW. In vitro urea dependent pH changes by human salivary bacteria and dispersed artificial mouth bacterial plaques. Arch Oral Biol, 32: 181-9, 1987.
29. Sissons CH, Perinpanayagam HER, Hancock EM, Cutress TW. pH regulation of urease levels in Streptococcus salivarius. J Dent Res, 69(5): 1131-7, 1990.
30. Sissons CH, Perinpanayagam HER, Hancock EM. Processes involved in the regulation of urease levels in Streptococcus salivarius by pH. Oral Microbiol Immunol, 7: 159-64, 1992.
31. Badet C, Thebaud NB. Ecology of Lactobacilli in the oral cavity: A Review of literature. The Open Microbial J, 2: 38-48, 2008.
32. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci, 113: 188-96, 2005. (Pubitemid 40880663)
33. Quwehand AC. Antimicrobial components from lactic acid bacteria. In Lactic acid bacteria: microbiology and functional aspects 2nd ed., Salminen S, von Wright A, Ed., New York: Dekker Inc: 139: 160, 1998.
34. Allaker RP, Douglas CW. Novel anti-microbial therapies for dental plaque- related diseases. Int J Antimicrob Agents, 33(1): 8-13, 2009.
35. Polonskaia MS. Antibiotic substances in acidophil bacteria. Mikrobiologiia, 21: 303-10, 1952.
36. Nase L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, Korpela R, Meurman JH. Effect of long term consumption of a probiotic bacterium, Lactobacillus Rhamnosus GG in milk on dental caries and caries risk in children. Caries Res, 35 (5): 412-20, 2001. (Pubitemid 33636860)
37. Ahola AJ, Yli Knuuttila H, Suomalainen T, Poussa T, Ahlstrom A, Meurman JH, Korpela R. Short term consumption of probiotic- containing cheese and its effect on dental caries risk factors. Arch Oral Biol, 47(11): 799-804, 2002. (Pubitemid 35442113)
38. Nikawa H, Makihira S, Fukushima H, Nishimura H, Ozaki Y, Ishida K, Darmawan S, Hamada T, Hara K, Matwumoto A, Aimi R. Lactobacillus Reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol, 95(2): 219-23, 2004. (Pubitemid 38993329)
39. Simark-Mattsson C, Emilson CG, Hakansson EG, Jacobsson C, Roos K, Halm S. Lactobacillus-mediated interference of mutans streptococci in caries-free vs. caries-active subjects. Eur J Oral Sci, 115: 308-14, 2007.
40. Drucker DB, Green RM. The relative cariogenicity of different streptococci in the gnotobiotic WAG/RIJ rat. Arch Oral Biol, 26(7): 599-606, 1981. (Pubitemid 11000430)
41. John R, Prabhu NT, Munshi AK. Effect of short-term antibiotic therapy on salivary S. mutans levels in children. J Ind Soc Pedod Preven Dent, 14(4): 123-7, 1996.
42. Goodson JM, Tanner A. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol, 7(2): 113-7, 1992.
43. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science, 264: 375-82, 1994. (Pubitemid 24178900)
44. Preus HR, Lassen J, Aass AM et al. Bacterial resistance following subgingival and systemic administration of minocycline. J Clin Periodontol, 22: 380-4, 1995.
45. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res, 11: 160-7, 1997.
46. Tenover FC. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis, 33: 108-15, 2001.
47. Roberts MC. Antibiotic toxicity, interactions and resistance development. Periodontal 2000, 28: 280-97, 2002.
48. Knoll-Kohler E, Stiebel J. Amine fluoride gel affects the viability and the generation of superoxide anions in human polymorphonuclear leukocytes: an in vitro study. Eur J Oral Sci, 110: 296-301, 2002.
49. Lachenmeier DW. Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. J Occup Med Toxicol, 3: 26, 2008.
50. McCullough MJ, Farah CS. The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes. Aust Dent J, 53(4): 302-5, 2008.
51. Neumegen RA, Fernandez-Alba AR, Chisti Y. Toxicities of triclosan, phenol, and copper sulfate in activated sludge. Environ Toxicol, 20(2): 160-4, 2005.
52. Tichy J, Novak J. Extraction, assay and analysis of antimicrobials from plants with activity against dental pathogens (Streptococcus sp.). J Altern Complement Med, 4(1): 39-45, 1998. (Pubitemid 128538824)
53. Badria FA, Zidan OA. Natural products for dental caries prevention. J Med Food, 7(3): 381-4, 2004. (Pubitemid 39299501)
54. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev, 12(4): 564-82, 1999. (Pubitemid 29484747)
55. Kalemba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem, 10(10): 813-29, 2003. (Pubitemid 36443237)
56. Kim HS. Do not put too much value on conventional medicines. J Ethnopharmacol, 100(1-2): 37-9, 2005.
57. Tsao TF, Newnan MG, Kwok YY, Horikoshi AK. Effetc of Chinese and western antimicrobial agents on selected oral bacteria. J Dent Res, 61(9): 1103-6, 1982. (Pubitemid 13241369)
58. Hwang JK, Shim JS, Pyun YR. Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. Fitoterapia, 71(3); 321-3, 2000. (Pubitemid 30323683)
59. Hu JP, Takahashin N, Yamada T. Coptidis rhizome inhibits growth and proteases of oral bacteria. Oral Dis, 6(5): 297-302, 2000.
60. Kastura H, Tsukiyama RI, Suzuki A, Kobayashi M. In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob Agents Chemother, 45(11): 3009-13, 2001. (Pubitemid 32988821)
61. Hwang JK, Chung JY, Baek NI, Park JH. Isopanduratin A from Kaempferia pandurata as an active antibacterial agent against cariogenic Streptococcus mutancs. Int J Antimicrob Agents, 23(4): 377-81, 2004.
62. Xiao J, Liu Y, Zuo YL, Li JY, Ye L, Zhou XD. Effects of Nidus Vespae extract and chemical fractions on the growth and acidogenicity of oral microorganisms. Arch Oral Biol, 51(9): 804-13, 2006. (Pubitemid 44233484)
63. Song JH, Kim SK, Chang KW, Han SK, Yi HK, Jeon JG. In vitro inhibitory effects of Polygonum cuspidatum on bacterial viability and virulence factors of Streptococcus mutans and Streptococcus sobrinus. Arch Oral Biol, 51(12): 1131-40, 2006.
64. Liu XT, Pan Q, Shi Y, Williams ID, Sung HH, Zhang Q et al. entrosane and labdane diterpenoids from Sagittaria sagittifolia and their antibacterial activity against three oral pathogens. J Nat Prod, 69(2): 255-60, 2006.
65. Liu XT, Shi Y, Yu B, Williams ID, Sung HH, Zhang Q et al. Antibacterial diterpenoids from Sagittaria pygmaea. Planta Med, 73(1): 84-90, 2007. (Pubitemid 46909857)
66. Wong RWK, Haqq U, Samaranayake L, Yuen MKZ, Seneviratne CJ, Kao R. Antimicrobial activity of Chinese medicine herbs against common bacteria in oral biofilm. A Pilot study. Int J Oral Maxillo Surg, 39: 599-605, 2010.
67. Hirasawa M, Shouji, N, Neta T, Fukushima K, Takeda K. Three kinds of antibacterial components from Lentinus edodes (Berk.). Int J Antimicrob Agents, 11(2): 151-7, 1999.
68. Yamada Y, Yamamoto A, Yoneda N, Nakatani N. Identification of kaempferol from the leaves of Diospyros kaki and its antimicrobial activity against Streptococcus mutans. Biocontrol Sci, 4: 97-100, 1999. (Pubitemid 29458102)
69. Jayaprakasha, Selve GK, Sakariah K. Antibacterial and antioxidant activities of grape (Vitis vinifera) seed extracts. Food Research International, 36(2): 117-22, 2003. (Pubitemid 37060481)
70. Wolinsky LE, Mania S, Nachnani S, Ling S. The inhibiting effect of aqueous.Azadirachta indica (Neem) extract upon bacterial properties influencing in vitro plaque formation. J Dent Res, 75(2): 816-22, 1996. (Pubitemid 32763616)
71. Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum linn (Tulsi) with a note on eugenol and its pharmacological actions. A short review. Indian J Physiol Pharmacol, 49(2): 125-31, 2005. (Pubitemid 40675735)
72. Viyoch J, Pisutthanan N, Faikreua A, Nupangta K, Wangtorpol K, Ngokkuen J. Evaluation of invitro antimicrobial activity of thai basil oils and their micro-emulsion formulae against Propionibacterium acnes. Int J Cosmet Sci, 28(2): 125-33, 2006.
73. Geeta, Vasudevan DM, Kedlaya R, Deepa S, Ballal M. Activity of Ocimum sanctum (the traditional Indian medicinal plant) against enteric pathogens. Ind J Med Sci, 55(8): 434-8, 472, 2001.
74. Magesh V, Lee JC, Ahn KS, Lee HJ, Lee EO, Shim BS et al. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung cancer cells. Phytother Res, 23(10): 1385-91, 2009.
75. Pooja A, Nagesh L, Murlikrishnan. Evaluation of the antimicrobial activity of various concentrations of Tulsi (Ocimum sanctum) extract against Streptococcus mutans: An in vitro study. Ind J Dent Res, 21(3): 357-9, 2010.
76. Hamilton-Miller J.M.T. Anti-cariogenic properties of tea (Camellia sinensis). J Med Microbiol, 50(4): 299-302, 2001. (Pubitemid 32239014)
77. Gianmaria F. Ferrazzano, Ivana Amato, Aniello Ingenito, Antonino De Natale, Antonino Pollio. Anti-cariogenic effects of polyphenols from plant stimulant beverages (cocoa, coffee, tea). Fitoterapia, 80(5): 255-62, 2009.
78. Fischer E, Stahel R. Zur Kenntniss der Xylose. Ber Dtsch Chem Ges, 24: 528-39, 1891.
79. Bertrand MG. Recherches zur quelques dérivés du xylose. Bull Soc Chim. Paris, 5: 554-7, 1891.
80. Scheinin A, Mäkinen KK, Ylitalo K. Turku sugar studies: I. An intermediate report on the effect of sucrose, fructose and xylitol diets on the caries incidence in man. Acta Odontol Sand, 32(6): 383-412, 1974.
81. Scheinin A, Mäkinen KK. The effect of various sugars on the formation and chemical composition of dental plaque. Int Dent J, 21: 302-21, 1971.
82. Scheinin A, Mäkinen KK. Effect of sugars and sugar mixtures on dental plaque. Acta Odontol Scand, 30(2): 235-57, 1972.
83. Mäkinen KK, Scheinin A. Turku sugar studies: II. Preliminary biochemical and general findings. Acta Odontol Scand, 32(6): 413-21, 1974.
84. Mouton C, Scheinin A, Mäkinen KK. Effect of plaque on a xylitol containing chewing gum: A pilot study. Acta Odontol Scand, 33(1): 27-31, 1975.
85. Mouton C, Scheinin A, Mäkinen KK. Effect of plaque on a xylitol containing chewing gum: A clinical and biochemical study. Acta Odontol Scand, 33(1): 33-40, 1975.
86. Mouton C, Scheinin A, Mäkinen KK. Effect of a xylitol chewing gum on plaque quantity and quality. Acta Odontol Scand, 33(5): 251-7, 1975.
87. Scheinin A, Mäkinen KK. Eds. Turku sugar studies. Acta Odontol Scand, 33(Suppl 70): 1-30, 1975.
88. Scheinin A, Bánóczy J. Xylitol and caries: the collaborative WHO oral disease preventive programme in Hungary. Int Dent J, 35(1): 50-7, 1985.
89. Kandelman D, Gagnon G. Clinical results after 12 months from a study of the incidence and progression of dental caries in relation to consumption of chewing gum containing xylitol in school preventive programs. J Dent Res, 66(8): 1407-11, 1987.
90. Isokangas P, Alanen P, Tiekso J, Mäkinen KK. Xylitol chewing gum in caries prevention: a field study in children at caries-active ages. J Am Dent Assoc, 117(2): 315-20, 1988.
91. Mäkinen KK. New biochemical aspects of sweetners. Int Dent J, 35: 23-35, 1985.
92. Mäkinen KK, Isokangas P. Relationship between carbohydrate sweetners and oral diseases. Prog Food Nut Sci, 12: 73-109, 1988.
93. Edwardsson S, Berkhed D, Mejare B. Acid production from lycasin, maltitol, sorbitol and xylitol by oral streptococci and lactobacilli. Acta Odontol Scand, 35(5): 257-63, 1977. (Pubitemid 8207991)
94. Havenaar R, Huis In't Veld JHJ, Backer Dirke O, de Stoppelaar JD. Some bacteriological aspects of sugar substitutes. In: Guggenheim, Ed., Health and sugar substitutes. Basel: Karger, 192-8, 1979.
95. Mäkinen KK, Virtanen KK. Effect of 4.5 year use of xylitol and sorbitol on plaque. J Dent Res, 57(3): 441-6, 1978. (Pubitemid 9002043)
96. Mäkinen KK, Söderling E, Hämäläinen K, Antonen P. Effect of long term use of xylitol on dental plaque. Proc Finn Dent Soc, 81(1): 28-35, 1985.
97. Assev S, Vegarud G, Rölla G. Growth inhibition of streptococcus mutans strain OZM 176 by xylitol. Acta Pathol Microbiol Immunol Scand Sect B, 88: 61-3, 1980. (Pubitemid 10184093)
98. Vadeboncoeur C, Trahan L, Mouton C, Mayrand D. Effect of xylitol on the growth and glycolysis of acidogenic oral bacteria. J Dent Res, 62(8): 882-4, 1983. (Pubitemid 13011289)
99. Trahan L, Bareil M, Gauther L, Vadeboncoeur C. Transport and phosphorylation of xylitol by a fructose phosphotransferace system in streptococcus mutans. Caries Res, 19(1): 53-63, 1985.
100. Mäkinen KK. Latest dental studies on xylitol and mechanisms of action of xylitol in caries limitation; In Grenby TH (Ed): Progress in sweeteners, London, Elsevier, 331-62, 1989.
101. Trahan L. Xylitol: a review of its action on mutans streptococci and dental plaque - its clinical significance. Int Dent J, 45 (1 Suppl 1): 77-92, 1995.
102. Mäkinen KK. Can the pentitol-hexitol theory explain the clinical observations made with xylitol? Med Hypotheses, 54: 603-13, 2000. (Pubitemid 30311552)
103. Milgrom P, Ly KA, Roberts MC, Rothen M, Meuller G, Yamaguchi DK. Mutans streptococci dose response to xylitol chewing gum. J Dent Res, 85(2): 177-81, 2006. (Pubitemid 43827752)
104. Mäkinen KK, Alanen PA, Isokangas P, Isotupa K, Sööderling E, Mäkinen PL, Wenhui W, Weijan W, Xiaochi C, Yi W, Boxue Z. Thirty-ninemonth xylitol chewing gum programme in initially eight year old school children: a feasibility study focusing on mutans streptococci and lactobacilli. Int Dent J, 58(1): 41-50, 2008.
105. Loesche WJ, Grossman NS, Earnest R, Corpron R. The effect of chewing xylitol gum on the plaque and salivary levels of Streptococcus mutans. J Am Dent Assoc, 108(4): 587-92, 1984.
106. Mäkinen KK. Dietary prevention of dental caries by xylitol-clinical effectiveness and safety. J Appl Nutr, 44: 16-28, 1991.
107. Mäkinen KK. Prevention of dental caries with xylitol- A potential dietary procedure for self-care and population-level use in young adults. J Am College Health, 41: 172-80, 1993. (Pubitemid 23084414)
108. Peldyak J, Mäkinen KK. Xylitol for caries prevention. J Dent Hygiene, 76(4): 276-85, 2002.
109. Sanchita Bhattacharya, Salima Virani, Mashenka Zavro, Gerhard J. Haas. Inhibition of Streptococcus Mutans and Other Oral Streptococci by Hop (Humulus Lupulus L.) Economic Botany, 57(1): 118-25, 2003. (Pubitemid 36821231)
110. Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol, 19(3): 150-4, 2004. (Pubitemid 38649607)
111. Chung JY, Choo JH, Lee MH, Hwang JK. Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine, 13(4): 261-6, 2006. (Pubitemid 43255326)
112. Bianchini, Bedendo IP. Efeito antibiótic do própolis sobre bactérias fitopatogênicas. Piracicaba: Scientia Agrícola; 1988.
113. Manara LRB, Anconi SI, Gromatzky A, conde MC, Bretz WA. Utilização da própolis em odotnologia. [The use of propolis in dentistry]. Rev Fac Odontol Bauru, 7(3/4): 15-20, 1999.
114. Silva EB. Efeito da a ção da própolis na lamina própria da mucosa buccal de ratos: estudo histologico. Robrac, 9(28): 4-8, 2000.
115. Fernandes A Jr, Orsi RO, Sforcin JM, Rall VLM, Funari SRC, Barbosa L. The antibacterial activity of propolis produced by Apis mellifera L. and Brazilian stingless bees. J Venom Anim Toxins, 7(2): 173-82, 2001.
116. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH. Effects of compounds found in propolis on Streptococccus mutans growth and on glucosyltransferace activity. Antimicrob Agents Chemother, 46(5): 1302-9, 2002. (Pubitemid 34415306)
117. Silvana Alves de CD, Azizedite GG, Fernando JMA. Effect of a propolis extract on Streptoccocus mutans counts in vivo. J Appl Oral Sci, 15(5): Bauru Sept/Oct, 2007.
118. Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, Salih B. Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol Res, 160(2): 189-95, 2005. (Pubitemid 40406353)
119. Feres M, Figueiredo LC, Barreto IM, Coelho MH, Araujo MW, Cortelli SC. In vitro antimicrobial activity of plant extracts and propolis in saliva samples of healthy and periodontally-involved subjects. J Int Acad Periodontol, 7(3): 90-6, 2005.
120. Menezes SMS, Cordeiro LN, Viana GSB. Punica granatum (pomegranate) extract is active against dental plaque. J Herb Pharmacotherapy, 6: 79-92, 2006. (Pubitemid 44964095)
121. Vasconcelos LCDS, Sampaio FC, Sampaio MCC, Pereira MDSV, Higino JS, Peixoto MHP. Minimum inhibitory concentration of adherence of Punica granatum Linn (pomegranate) gel against S. mutans, S. mitis and C. albicans. Braz Dent J, 17(3): 223-7, 2006.
122. Sofrata AH, Claesson RL, Lingström PK, Gustafsson AK. Strong antibacterial effect of miswak against oral microorganisms associated with periodontitis and caries. J Periodontol, 79(8): 1474-9, 2008.
123. Akihiro O, Harafumie Saito,Tsugio Matsuhisa. Screening of Antibacterial Activities of Edible Plants against Streptococcus mutans. Food Sci Technol Res, 14 (2): 190-3, 2008.
124. Wu CD. Grape products and oral health. J Nutr, 139(9): 1818 'S'- 23 'S', 2009.
125. Didry N, Dubreuil L, Trotin F, Pinkas M. Antimicrobial activity of aerial parts of Drosera peltata. Smith on oral bacteria. J Ethnopharmacol, 60(1): 91-6, 1998. (Pubitemid 28098345)
126. Hu JP, Takahashi N, Yamada T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis, 6(5): 297-302, 2000.
127. Park KM, You JS, Lee HY, Baek NI, Hwang JK. Kuwanon G, An antibacterial agent from the root bark of Morus alba against oral pathogens. J Ethnopharmacol, 84(2-3): 181-5, 2003. (Pubitemid 36324257)
128. Nostro A, Cannatelli MA, Crisafi G, Musolino AD, Procopio F, Alonzo V. Modifications of hydrophobicity, in vitro adherence and cellular aggregation of Streptococcus mutans by Helichrysum italicum extract. Lett Appl Microbiol, 38(5): 423-7, 2004. (Pubitemid 38534810)
129. Nagata H, Inagaki Y, Yamamoto Y, Maeda K, Kataoka K, Osawa K. Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria. Oral Microbiol Immunol, 21(3): 159-63, 2006.
130. Sterer N. Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis. J Med Food, 9(2): 290-2, 2006. (Pubitemid 44036124)
131. Prabu GR, Gnanamani A, Sadulla S. Guaijaverin. A plant flavonoid as potential antiplaque agent against Streptococcus mutans. J Appl Microbiol, 101(2): 487-95, 2006. (Pubitemid 44060431)
132. Song JH, Kim SK, Chang KW, Han SK, Yi HK, Jeon JG. In vitro inhibitory effects of Polygonum cuspidatum on bacterial viability and virulence factors of Streptococcus mutans and Streptococcus sobrinus. Arch Oral Biol, 51(12): 1131-40, 2006.
133. Silva ML, Coimbra HS, Pereira AC, Almeida VA, Lima TC,Costa ES. Evaluation of Piper cubeba extract, cubebin and its semi-synthetic derivatives against oral pathogens. Phytother Res, 21(5): 420-2, 2007. (Pubitemid 46715080)
134. Smullen J, Koutsou GA, Foster HA, Zumbe A, Storey DM. The antibacterial activity of plant extracts containing polyphenols against Streptococcus mutans. Caries Res, 41(5): 342-9, 2007.
135. Tsui VW, Wong RW, Rabie AB. The inhibitory effects of naringin on the growth of periodontal pathogens in vitro. Phytother Res, 22(3): 401-6, 2008. (Pubitemid 351397446)
136. Bispo MD, Mourao RHV, Franzotti EM et al. Antinociceptive and antiedematogenic effects of the abueous extract of Hyptis pectinata leaves in experimental animals. J Ethnopharmacol, 76(1): 81-6, 2001. (Pubitemid 32510735)
137. Alviano WS, Mendonca-Filho RR, Alviano DS et al. Antimicrobial activity of Croton cajucara Benth linalool-rich essential oil on artificial biofilms and planktonic microorganisms. Oral Microbiol Immunol, 20: 1-5, 2005.
138. Hammer KA, Dry L, Johnson M, Michalak EM, Carson CF, Riley TV. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiol Immunol, 18(6): 389-92, 2003. (Pubitemid 37372900)
139. Shapiro S, Meir A, Guggenheim B. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbio Immunol, 9(4): 202-8, 1994.
140. Groppo FC, Bergamaschi C, Cogok, Franz-Montan M, Motta RH, de Andrade ED. Use of phytotherapy in dentistry. Phytother Res, 22(8): 993-8, 2008.
141. Sanjib Bhattacharya. Phytosomes: Emerging Strategy in Delivery of Herbal Drugs and Nutraceuticals. Pharma Times, 41 (3): 9-12, 2009.
142. Bombardelli E, Curri SB, Loggia RD, Del NP, Tubaro A, Gariboldi P. Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia, 60: 1-9, 1989.
143. Murray. Phytosomes-Increase the absorption of herbal extract. Available at: http://www.doctormurray.com/articles/silybin.htm
144. Bombardelli E, Spelta M, Loggia RD, Sosa S, Tubaro A. Aging skin: Protective effect of silymarin-Phytosome. Fitoterapia, 62(2): 115-22, 1991.
145. Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle Phytosome: a silybinphosphatidylcholine complex. Altern Med Rev, 10(3): 193-203, 2005. (Pubitemid 41384033)
146. Yanyu x, Yunmei S, Zhipeng C, Quineng P. The preparation of silybinphospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 3; 307(1): 77-82, 2006. (Pubitemid 41773254)
147. Vitamedics, Phytosome products. Available at http://www.vitamedics.com
148. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin phosphatidylcholine complex in healthy human subjects. Eur J Drug Metab Pharmacokinet, 15: 333-8, 1990.
149. Bombardelli E. Phytosomes in functional cosmetics. Fitoterapia, 65(5): 320-7, 1994.